Our data demonstrated that the serum proinflammatory cytokines IL-1β, TNF-α, IL-2, IFN-γ, and IL-4 and the anti-inflammatory cytokine IL-10 were dysregulated in diabetes and improved by OI intervention. This evidence concerns the gene IL1B and diabetes mellitus.